BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 5773075)

  • 1. Spermatic and peripheral venous levels of gonadotropin and testosterone in a teratoma with embryonal cell carcinoma.
    Wieland RG; Guevara A; Hallberg MC; Zorn EM; Pohlman C
    J Clin Endocrinol Metab; 1969 Mar; 29(3):398-400. PubMed ID: 5773075
    [No Abstract]   [Full Text] [Related]  

  • 2. Leydig cell function in men with gonadotrophin-producing testicular tumors.
    Kirschner MA; Wider JA; Ross GT
    J Clin Endocrinol Metab; 1970 Apr; 30(4):504-11. PubMed ID: 4244874
    [No Abstract]   [Full Text] [Related]  

  • 3. Leydig cell hyperplasia due to a testicular embryonal carcinoma producing human chorionic gonadotropin.
    Asa SL; Bayley TA; Kovacs K; Horvath E
    Andrologia; 1984; 16(2):146-55. PubMed ID: 6204557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alphafetoprotein in mixed germ cell tumour (seminoma and embryonal carcinoma) of testis-a case report.
    Deshpande AD; Hayatnagarkar NP; Patil SD
    Indian J Pathol Microbiol; 1981 Jul; 24(3):205-8. PubMed ID: 6172377
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical evaluation of human chorionic gonadotropin levels in men with testicular tumors.
    Cochran JS; Walsh PC; Porter JC; Nicholson TP; Peters PC
    Surg Forum; 1974; 25(0):542-3. PubMed ID: 4474717
    [No Abstract]   [Full Text] [Related]  

  • 6. [Determination of specific markers in the blood in tumors of the testis].
    Sakalo VS; Klimenko IA; Iaremko VN; Zaparin VK
    Klin Khir (1962); 1990; (5):47-8. PubMed ID: 1697352
    [No Abstract]   [Full Text] [Related]  

  • 7. Is testosterone involved in the initiation of spermatogenesis in humans? A clinicopathological presentation and physiological considerations in four patients with Leydig cell tumours of the testis or secondary Leydig cell hyperplasia.
    Chemes HE; Pasqualini T; Rivarola MA; Bergadá C
    Int J Androl; 1982 Jun; 5(3):229-45. PubMed ID: 7118264
    [No Abstract]   [Full Text] [Related]  

  • 8. Suppression of gonadotropins inhibits gonadal tumorigenesis in mice transgenic for the mouse inhibin alpha-subunit promoter/simian virus 40 T-antigen fusion gene.
    Kananen K; Rilianawati ; Paukku T; Markkula M; Rainio EM; Huhtaniemi I
    Endocrinology; 1997 Aug; 138(8):3521-31. PubMed ID: 9231807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Histopathology of testicular germ cell tumors].
    Morinaga S; Sasano N
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2460-7. PubMed ID: 6210048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discordance of human chorionic gonadotropin and alpha-fetoprotein in testicular teratocarcinomas.
    Braunstein GD; McIntire KR; Waldmann TA
    Cancer; 1973 May; 31(5):1065-8. PubMed ID: 4122298
    [No Abstract]   [Full Text] [Related]  

  • 11. [Endocrine interrelationships in patients with malignant testicular tumours (author's transl)].
    Lunglmayr G; Kuber W; Spona J
    Wien Klin Wochenschr; 1981 Jun; 93(13):411-4. PubMed ID: 6791391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired hyperstrogenism of testicular origin without evidence of neoplasia.
    Smith SR
    J Clin Endocrinol Metab; 1971 Jan; 32(1):77-82. PubMed ID: 4321498
    [No Abstract]   [Full Text] [Related]  

  • 13. Testicular venous sampling in determining the possible origin of tumour markers and its influence on management.
    Williams GS; Modi CS; Inglis JA
    Andrologia; 2006 Oct; 38(5):195-6. PubMed ID: 16961573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difficulties in the diagnosis of metastatic testicular teratoma.
    Huddart R; Moore NR; Williams MV; Dixon AK
    Br J Radiol; 1990 Jul; 63(751):569-72. PubMed ID: 2390694
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biological markers for tumours of the testis. Their use in diagnosis, prognosis and follow-up in 200 cases (author's transl)].
    Bellet D; Caillaud JM; Droz JP; Delarue JC; Bohuon C
    Nouv Presse Med; 1981 Nov; 10(40):3293-7. PubMed ID: 6170931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical outcome of adult testicular tumor. I. Study on patients of nonseminoma with negative human chorionic gonadotropin].
    Kawai T; Sakuramoto T; Kihara K
    Hinyokika Kiyo; 1984 May; 30(5):627-37. PubMed ID: 6089532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of biologic tumor markers in testicular cancer.
    Javadpour N
    Cancer Treat Rep; 1979; 63(9-10):1643-7. PubMed ID: 91433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal profile of Leydig cell tumors with gynecomastia.
    Bercovici JP; Nahoul K
    Prog Clin Biol Res; 1985; 203():503-6. PubMed ID: 3832101
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
    Lange PH
    Natl Cancer Inst Monogr; 1978 Dec; (49):215-7. PubMed ID: 86163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of biologic tumor markers in testicular cancer.
    Javadpour N
    Cancer; 1980 Apr; 45(7 Suppl):1755-61. PubMed ID: 6154517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.